LATEST NEWS
| ADIENNE is an integrated biopharmaceutical group of companies based in Lugano, Switzerland, with a proprietary portfolio of orphan-designated marketed medicinal product, clinical and preclinical product candidates focusing on critical conditions of high unmet medical needs. | ADIENNE EXHIBITING AT EBMT 2019 IN FRANKFURT - ADIENNE will be exhibiting at the 45th Annual Meeting of the European Society of Blood and Marrow Transplantation, taking place at the Messe Frankfurt from 24th to 27th March. Meet us at Booth A33 to see what's new! |
| ADIENNE aims to develop a range of product candidates for orphan diseases for which existing treatment options are limited, the patient population is small and the clinical needs for therapies is high. | ADIENNE GRANTED AIFA MANUFACTURING AUTHORIZATION - Following inspection performed by AIFA (Agenzia Italiana del Farmaco) last December, on February 12, 2019 ADIENNE has been granted the authorization n. aM - 12/2019 for the manufacturing of investigational biotech products at its plant located in Caponago (Italy). |
